retatrutide side effects clinical trial results Retatrutide Trial – My Endo Consult retatrutide clinical trial information Safety,

If you have insurance that covers brand-name GLP-1 medications, your provider may prescribe Wegovy (semaglutide 2.4 mg) or Zepbound (tirzepatide) since these are FDA-approved for weight management

9 (16): R58890

Proactive strategies can minimize electrolyte disturbance risk and optimize outcomes for patients on GLP-1 therapy

Do not eat or drink anything for 15 to 30 minutes before administration

This is to minimise side effects and aid a smooth transition between the medications

These side effects, such as nausea, vomiting, and abdominal discomfort, are common when the body is adjusting to the medication, and beginning with a lower dose helps your digestive system acclimate gradually to its effects